12264 related articles for article (PubMed ID: 11668469)
41. Immunohistochemical study of melanocytic differentiation antigens in cutaneous malignant melanoma. A comparison of six commercial antibodies and one non-commercial antibody in nodular melanoma, superficially spreading melanoma and lentigo maligna melanoma.
Kocan P; Jurkovic I; Böör A; Dudríková K; Krajcár R; Benický M; Kromydaki A
Cesk Patol; 2004 Apr; 40(2):50-6. PubMed ID: 15233017
[TBL] [Abstract][Full Text] [Related]
42. Comparison of immunohistochemical labelling of melanocyte differentiation antibodies melan-A, tyrosinase and HMB 45 with NKIC3 and S100 protein in the evaluation of benign naevi and malignant melanoma.
Orchard GE
Histochem J; 2000 Aug; 32(8):475-81. PubMed ID: 11095072
[TBL] [Abstract][Full Text] [Related]
43. Microphthalmia transcription factor immunohistochemistry: a useful diagnostic marker in the diagnosis and detection of cutaneous melanoma, sentinel lymph node metastases, and extracutaneous melanocytic neoplasms.
O'Reilly FM; Brat DJ; McAlpine BE; Grossniklaus HE; Folpe AL; Arbiser JL
J Am Acad Dermatol; 2001 Sep; 45(3):414-9. PubMed ID: 11511840
[TBL] [Abstract][Full Text] [Related]
44. p75 nerve growth factor receptor staining helps identify desmoplastic and neurotropic melanoma.
Kanik AB; Yaar M; Bhawan J
J Cutan Pathol; 1996 Jun; 23(3):205-10. PubMed ID: 8793654
[TBL] [Abstract][Full Text] [Related]
45. Microphthalmia transcription factor immunohistochemistry for FNA biopsy of ocular malignant melanoma.
Perrino CM; Wang JF; Collins BT
Cancer Cytopathol; 2015 Jul; 123(7):394-400. PubMed ID: 25711993
[TBL] [Abstract][Full Text] [Related]
46. MLANA/MART1 and SILV/PMEL17/GP100 are transcriptionally regulated by MITF in melanocytes and melanoma.
Du J; Miller AJ; Widlund HR; Horstmann MA; Ramaswamy S; Fisher DE
Am J Pathol; 2003 Jul; 163(1):333-43. PubMed ID: 12819038
[TBL] [Abstract][Full Text] [Related]
47. Ex vivo quality-switched ruby laser irradiation of cutaneous melanocytic lesions: persistence of S-100-, HMB-45- and Masson-positive cells.
Kopera D; Hohenleutner U; Stolz W; Landthaler M
Dermatology; 1997; 194(4):344-50. PubMed ID: 9252755
[TBL] [Abstract][Full Text] [Related]
48. Oral melanocytic lesions: differences in expression of HMB-45 and S-100 antigens in round and spindle cells of malignant and benign lesions.
Gazit D; Daniels TE
J Oral Pathol Med; 1994 Feb; 23(2):60-4. PubMed ID: 8164154
[TBL] [Abstract][Full Text] [Related]
49. Immunohistochemical characteristics of melanoma.
Ohsie SJ; Sarantopoulos GP; Cochran AJ; Binder SW
J Cutan Pathol; 2008 May; 35(5):433-44. PubMed ID: 18399807
[TBL] [Abstract][Full Text] [Related]
50. [Activation of epidermal melanocytes is independent of epithelial proliferation and vascularization. Immunohistologic study using HMB-45 antibody with review of the literature].
Lommel K; Tronnier M; Wolff HH
Hautarzt; 1996 Aug; 47(8):616-23. PubMed ID: 8964704
[TBL] [Abstract][Full Text] [Related]
51. SM5-1: a new monoclonal antibody which is highly sensitive and specific for melanocytic lesions.
Trefzer U; Rietz N; Chen Y; Audring H; Herberth G; Siegel P; Reinke S; Königer P; Wu S; Ma J; Liu Y; Wang H; Sterry W; Guo Y
Arch Dermatol Res; 2000 Dec; 292(12):583-9. PubMed ID: 11214818
[TBL] [Abstract][Full Text] [Related]
52. Heterogeneity of Metastatic Melanoma: Correlation of MITF With Its Transcriptional Targets MLSN1, PEDF, HMB-45, and MART-1.
Zand S; Buzney E; Duncan LM; Dadras SS
Am J Clin Pathol; 2016 Sep; 146(3):353-60. PubMed ID: 27515936
[TBL] [Abstract][Full Text] [Related]
53. Comparison of MITF and Melan-A Immunohistochemistry During Mohs Surgery for Lentigo Maligna-Type Melanoma In Situ and Lentigo Maligna Melanoma.
Christensen KN; Hochwalt PC; Hocker TL; Roenigk RK; Brewer JD; Baum CL; Otley CC; Arpey CJ
Dermatol Surg; 2016 Feb; 42(2):167-75. PubMed ID: 26771682
[TBL] [Abstract][Full Text] [Related]
54. Clear cell sarcoma shows immunoreactivity for microphthalmia transcription factor: further evidence for melanocytic differentiation.
Granter SR; Weilbaecher KN; Quigley C; Fletcher CD; Fisher DE
Mod Pathol; 2001 Jan; 14(1):6-9. PubMed ID: 11211309
[TBL] [Abstract][Full Text] [Related]
55. Melan-A/Mart-1 expression in various melanocytic lesions and in non-melanocytic soft tissue tumours.
Orosz Z
Histopathology; 1999 Jun; 34(6):517-25. PubMed ID: 10383696
[TBL] [Abstract][Full Text] [Related]
56. The new AJCC guidelines in practice: utility of the MITF immunohistochemical stain in the evaluation of single-cell metastasis in melanoma sentinel lymph nodes.
Hutchens KA; Heyna R; Mudaliar K; Wojcik E
Am J Surg Pathol; 2013 Jun; 37(6):933-7. PubMed ID: 23629445
[TBL] [Abstract][Full Text] [Related]
57. Malignant melanoma of the oral mucosa in a 17-year-old adolescent girl.
D'Silva NJ; Kurago Z; Polverini PJ; Hanks CT; Paulino AF
Arch Pathol Lab Med; 2002 Sep; 126(9):1110-3. PubMed ID: 12204064
[TBL] [Abstract][Full Text] [Related]
58. The use of immunocytochemical study in the cytologic diagnosis of melanoma: evaluation of three antibodies.
Jing X; Michael CW; Theoharis CG
Diagn Cytopathol; 2013 Feb; 41(2):126-30. PubMed ID: 22021247
[TBL] [Abstract][Full Text] [Related]
59. Primary angiomatoid melanoma as an exceptional morphologic pattern in cutaneous melanoma. A case report and review of the literature.
Ramos-Rodríguez G; Ortiz-Hidalgo C
Actas Dermosifiliogr; 2015 Apr; 106(3):e13-7. PubMed ID: 25498159
[TBL] [Abstract][Full Text] [Related]
60. Is MAGE-1 expression in metastatic malignant melanomas really helpful?
Gajjar NA; Cochran AJ; Binder SW
Am J Surg Pathol; 2004 Jul; 28(7):883-8. PubMed ID: 15223957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
